WHO-GMP (World Health Organization - Good Manufacturing Practices) refers to the set of guidelines and quality standards established by the World Health Organization to ensure that pharmaceutical products are consistently produced and controlled to meet quality standards appropriate for their intended use. WHO-GMP focuses on safeguarding public health by promoting high-quality manufacturing processes globally, especially in countries where regulatory frameworks are still developing.
WHO-GMP establishes internationally benchmarked manufacturing criteria for premises, hygiene, sterile processing, quality control testing, and documentation to guarantee medicine safety, prevent hazardous batch deviations, and protect patients globally.
Rigorous international manufacturing benchmarks structured to ensure sterile, effective medicines:
Guarantee that medicines are manufactured under hygienic and controlled conditions.
Provide harmonized guidelines adaptable for manufacturers worldwide.
Minimize risks during manufacturing to avoid defective or unsafe products.
Aid countries and manufacturers in meeting international standards for pharmaceutical production.
Tangible clinical, commercial, and regulatory excellence:
Ensures pharmaceutical products meet international quality standards.
Supports export and import by complying with WHO-recognized guidelines.
Reduces risks related to substandard or counterfeit medicines.
Helps manufacturers meet requirements of WHO and many national regulatory authorities.
Promotes efficiency and reliability in pharmaceutical production.
Rigorous quality control requirements spanning the full pharmaceutical production chain:
Premises and equipment requirements.
Sanitation and hygiene practices.
Documentation and record-keeping.
Quality control and quality assurance systems.
Personnel qualifications and training.
Production processes and in-process controls.
Handling of materials and product storage.
Validation and qualification procedures.
Essential across pharmaceutical manufacturing, biotechnology, and health oversight bodies:
Finished formulation pharmaceutical manufacturers producing tablets, capsules, injectables, and syrups.
Biological and vaccine production facilities adhering to ultra-sterile containment protocols.
Active Pharmaceutical Ingredient (API) manufacturers and bulk chemical producers.
Third-party contract manufacturing organizations delivering compliant outsourced production.
National Regulatory Authorities implementing GMP frameworks and national drug oversight.
Adhering to WHO-GMP guidelines demonstrates your organization’s commitment to high-quality pharmaceutical manufacturing that protects patient health and meets international standards. It is essential for ensuring safe, effective, and reliable medicines worldwide.